The estimated Net Worth of Jack Phillips is at least $925 millier dollars as of 17 April 2024. Mr Phillips owns over 59,928 units of Accelerate Diagnostics Inc stock worth over $305,343 and over the last 5 years he sold AXDX stock worth over $0. In addition, he makes $619,962 as CEO et Pres & Director at Accelerate Diagnostics Inc.
Sign up
Mr Phillips AXDX stock SEC Form 4 insiders trading
Mr has made over 26 trades of the Accelerate Diagnostics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 59,928 units of AXDX stock worth $96,484 on 17 April 2024.
The largest trade he's ever made was exercising 350,000 units of Accelerate Diagnostics Inc stock on 8 March 2023 worth over $563,500. On average, Mr trades about 26,589 units every 30 days since 2019. As of 17 April 2024 he still owns at least 189,654 units of Accelerate Diagnostics Inc stock.
You can see the complete history of Mr Phillips stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Jack Phillips biography
Jack Phillips is the CEO, Pres & Director at Accelerate Diagnostics Inc.
What is the salary of Mr Phillips?
As the CEO et Pres & Director of Accelerate Diagnostics Inc, the total compensation of Mr Phillips at Accelerate Diagnostics Inc is $619,962. There are 2 executives at Accelerate Diagnostics Inc getting paid more, with John Phillips having the highest compensation of $12,300,900.
How old is Mr Phillips?
Mr Phillips is 55, he's been the CEO et Pres & Director of Accelerate Diagnostics Inc since . There are 9 older and 5 younger executives at Accelerate Diagnostics Inc. The oldest executive at Accelerate Diagnostics Inc is Jack Schuler, 79, who is the Independent Director.
What's Mr Phillips's mailing address?
Jack's mailing address filed with the SEC is C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB ROAD, SUITE 470, TUCSON, AZ, 85714.
Insiders trading at Accelerate Diagnostics Inc
Over the last 12 years, insiders at Accelerate Diagnostics Inc have traded over $26,833,308 worth of Accelerate Diagnostics Inc stock and bought 16,366,880 units worth $209,384,489 . The most active insiders traders include Jack W Schuler, Larry N Feinberg et Matthew Strobeck. On average, Accelerate Diagnostics Inc executives and independent directors trade stock every 16 days with the average trade being worth of $132,645. The most recent stock trade was executed by Hany Massarany on 28 June 2024, trading 4,737 units of AXDX stock currently worth $7,627.
What does Accelerate Diagnostics Inc do?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
What does Accelerate Diagnostics Inc's logo look like?
Complete history of Mr Phillips stock trades at Accelerate Diagnostics Inc
Accelerate Diagnostics Inc executives and stock owners
Accelerate Diagnostics Inc executives and other stock owners filed with the SEC include:
-
John Phillips,
Chief Executive Officer, Chief Operating Officer, Director -
Steve Reichling,
Chief Financial Officer -
Jack Phillips,
CEO, Pres & Director -
Ron Price,
Senior Vice President, Head of Commercial Operations, Americas -
Roland Diggelmann,
Independent Director -
Louise Francesconi,
Independent Director -
Steve Reichling,
CFO & Chief Accounting Officer -
Ron Price,
Chief Commercial Officer of Americas -
Charles Watts,
Independent Director -
Frank ten Brink,
Independent Director -
Matthew Strobeck,
Independent Director -
Jack Schuler,
Independent Director -
Mark Miller,
Independent Director -
Thomas Brown,
Independent Director -
John Patience,
Independent Chairman of the Board -
Nedal Safwat,
Chief Strategy Officer -
Dr. Lawrence Mertz,
Sr. VP and Head of R&D -
John Meduri,
Chief Strategy Officer -
Laura Costa,
Sr. VP & Head of Global Customer Support -
Cherif Bousselham,
Sr. VP & Head of Sales - EMEA -
Gretchen Strohminger,
Sr. VP and Head of HR & Culture -
Michael Bridge,
Sr. VP, Gen. Counsel & Sec. -
Laura Pierson,
Investor Relations Officer -
Larry N Feinberg,
10% owner -
Pete Bantock,
CHIEF COMMERCIAL OFFICER -
Lawrence Mehren,
PRESIDENT AND CEO -
Marran H. Ogilvie,
Director -
Jennifer Regan,
Director -
Mark S. Black,
Director -
Ventures, Llc Abeja,
10% owner -
Romney Humphries,
Chief Scientific Officer -
Larry Michael Mertz,
Chief Technology Officer -
Hany Massarany,
Director -
Jack Phillips,
Chief Executive Officer -
Wayne Burris,
Director -
David Patience,
Chief Financial Officer